CAAP1 cDNA ORF clone, Homo sapiens(human)

The following CAAP1 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the CAAP1 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID Accession No. Definition **Vector *Turnaround time Price (USD) Select
OHu13647 NM_024828.4
Latest version!
Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 1, mRNA. pcDNA3.1-C-(k)DYK or customized vector
in pcDNA3.1-C-(k)DYK
$159.50-$223.30
$319.00
OHu13563 NM_001167575.1
Latest version!
Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 2, mRNA. pcDNA3.1-C-(k)DYK or customized vector 7-9 $188.30
$269.00
View Old Accession Versions >>
OHu13647 NM_024828.3 Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 1, mRNA. pcDNA3.1-C-(k)DYK or customized vector 7-9 $265.30
$379.00
Hide Old Accession Versions >>

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

  • Reference Sequences (Refseq)
    CloneID OHu13647
    Clone ID Related Accession (Same CDS sequence) NM_024828.3 , NM_024828.4
    Accession Version NM_024828.4 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 1086bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2019-12-30
    Organism Homo sapiens(human)
    Product caspase activity and apoptosis inhibitor 1 isoform 1
    Comment Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from BP228742.1, BC071953.1 and AF131768.1. On Nov 23, 2018 this sequence version replaced NM_024828.3. Transcript Variant: This variant (1) encodes the longer isoform (1). ##Evidence-Data-START## Transcript exon combination :: BC071953.1, SRR1660809.10313.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2146236, SAMN01820693 [ECO:0000348] ##Evidence-Data-END## ##RefSeq-Attributes-START## MANE Ensembl match :: ENST00000333916.8/ ENSP00000369431.3 RefSeq Select criteria :: based on conservation, expression, longest protein ##RefSeq-Attributes-END## COMPLETENESS: full length.

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    661
    721
    781
    841
    901
    961
    1021
    1081
    ATGACGGGGA AAAAGTCCTC CCGGGAGAAA CGGCGCAAAC GTAGCAGTCA GGAGGCGGCC 
    GCAGCGCTCG CGGCCCCGGA CATCGTACCC GCGTTGGCCA GCGGCAGCAG TGGAAGCACT
    AGCGGCTGCG GGAGCGCCGG GGGCTGCGGG AGCGTCAGCT GCTGTGGGAA CGCCAATTTT
    AGTGGAAGTG TCACCGGCGG TGGGAGCGGC GGCAGCTGTT GGGGCGGGAG CAGCGTGGAG
    CGCAGCGAGC GCCGGAAGCG GAGGAGTACC GACTCTTCCA GCGTCTCGGG CTCCTTGCAG
    CAGGAAACTA AATATATTTT GCCAACTTTG GAAAAAGAAT TATTCTTGGC AGAGCACAGT
    GACCTTGAAG AAGGTGGACT GGACCTGACT GTGTCATTGA AACCAGTTAG TTTCTATATA
    TCAGACAAAA AAGAAATGCT TCAGCAGTGC TTCTGTATTA TAGGAGAGAA AAAGTTACAG
    AAGATGCTTC CTGATGTGTT AAAGAACTGT TCAATAGAAG AAATTAAAAA ACTATGCCAG
    GAACAGTTAG AGCTCCTGTC TGAAAAAAAA ATTTTGAAGA TTCTTGAGGG TGACAATGGA
    ATGGACTCTG ATATGGAAGA GGAAGCAGAT GATGGTTCTA AGATGGGATC TGATTTAGTC
    AGTCAGCAAG ACATCTGTAT AGATTCTGCT TCATCCGTGA GAGAGAATAA GCAACCTGAA
    GGTTTGGAAT TAAAACAAGG AAAAGGGGAA GATAGTGATG TACTCAGTAT AAATGCAGAT
    GCTTATGACA GCGACATAGA AGGCCCATGC AACGAAGAAG CAGCTGCTCC CGAGGCACCA
    GAAAATACAG TCCAAAGTGA AGCTGGTCAG ATAGATGACC TGGAGAAAGA CATTGAGAAA
    AGTGTGAATG AGATTCTAGG ACTGGCAGAG TCTAGCCCAA ACGAACCCAA AGCAGCCACC
    CTGGCTGTTC CTCCACCAGA AGATGTTCAA CCTTCTGCAC AGCAACTGGA GCTGCTAGAA
    CTTGAGATGA GGGCAAGAGC GATTAAAGCC CTAATGAAAG CTGGTGATAT AAAAAAGCCA
    GCCTAG

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_079104.3
    CDS88..1173
    Translation

    Target ORF information:

    RefSeq Version NM_024828.4
    Organism Homo sapiens(human)
    Definition Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 1, mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_024828.4

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    661
    721
    781
    841
    901
    961
    1021
    1081
    ATGACGGGGA AAAAGTCCTC CCGGGAGAAA CGGCGCAAAC GTAGCAGTCA GGAGGCGGCC 
    GCAGCGCTCG CGGCCCCGGA CATCGTACCC GCGTTGGCCA GCGGCAGCAG TGGAAGCACT
    AGCGGCTGCG GGAGCGCCGG GGGCTGCGGG AGCGTCAGCT GCTGTGGGAA CGCCAATTTT
    AGTGGAAGTG TCACCGGCGG TGGGAGCGGC GGCAGCTGTT GGGGCGGGAG CAGCGTGGAG
    CGCAGCGAGC GCCGGAAGCG GAGGAGTACC GACTCTTCCA GCGTCTCGGG CTCCTTGCAG
    CAGGAAACTA AATATATTTT GCCAACTTTG GAAAAAGAAT TATTCTTGGC AGAGCACAGT
    GACCTTGAAG AAGGTGGACT GGACCTGACT GTGTCATTGA AACCAGTTAG TTTCTATATA
    TCAGACAAAA AAGAAATGCT TCAGCAGTGC TTCTGTATTA TAGGAGAGAA AAAGTTACAG
    AAGATGCTTC CTGATGTGTT AAAGAACTGT TCAATAGAAG AAATTAAAAA ACTATGCCAG
    GAACAGTTAG AGCTCCTGTC TGAAAAAAAA ATTTTGAAGA TTCTTGAGGG TGACAATGGA
    ATGGACTCTG ATATGGAAGA GGAAGCAGAT GATGGTTCTA AGATGGGATC TGATTTAGTC
    AGTCAGCAAG ACATCTGTAT AGATTCTGCT TCATCCGTGA GAGAGAATAA GCAACCTGAA
    GGTTTGGAAT TAAAACAAGG AAAAGGGGAA GATAGTGATG TACTCAGTAT AAATGCAGAT
    GCTTATGACA GCGACATAGA AGGCCCATGC AACGAAGAAG CAGCTGCTCC CGAGGCACCA
    GAAAATACAG TCCAAAGTGA AGCTGGTCAG ATAGATGACC TGGAGAAAGA CATTGAGAAA
    AGTGTGAATG AGATTCTAGG ACTGGCAGAG TCTAGCCCAA ACGAACCCAA AGCAGCCACC
    CTGGCTGTTC CTCCACCAGA AGATGTTCAA CCTTCTGCAC AGCAACTGGA GCTGCTAGAA
    CTTGAGATGA GGGCAAGAGC GATTAAAGCC CTAATGAAAG CTGGTGATAT AAAAAAGCCA
    GCCTAG

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    CloneID OHu13563
    Clone ID Related Accession (Same CDS sequence) NM_001167575.1
    Accession Version NM_001167575.1 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 651bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2019-12-27
    Organism Homo sapiens(human)
    Product caspase activity and apoptosis inhibitor 1 isoform 2
    Comment Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from BP228742.1, BP374752.1, BC071953.1 and AF131768.1. Transcript Variant: This variant (2) uses an alternate splice junction at the 3' end of the first exon compared to variant 1, that causes a frameshift. The resulting isoform (2) is shorter at the N-terminus compared to isoform 1. ##Evidence-Data-START## Transcript exon combination :: SRR1660805.44555.1, SRR1660807.135981.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2146236, SAMN01820693 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end.

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    ATGCTTCAGC AGTGCTTCTG TATTATAGGA GAGAAAAAGT TACAGAAGAT GCTTCCTGAT 
    GTGTTAAAGA ACTGTTCAAT AGAAGAAATT AAAAAACTAT GCCAGGAACA GTTAGAGCTC
    CTGTCTGAAA AAAAAATTTT GAAGATTCTT GAGGGTGACA ATGGAATGGA CTCTGATATG
    GAAGAGGAAG CAGATGATGG TTCTAAGATG GGATCTGATT TAGTCAGTCA GCAAGACATC
    TGTATAGATT CTGCTTCATC CGTGAGAGAG AATAAGCAAC CTGAAGGTTT GGAATTAAAA
    CAAGGAAAAG GGGAAGATAG TGATGTACTC AGTATAAATG CAGATGCTTA TGACAGCGAC
    ATAGAAGGCC CATGCAACGA AGAAGCAGCT GCTCCCGAGG CACCAGAAAA TACAGTCCAA
    AGTGAAGCTG GTCAGATAGA TGACCTGGAG AAAGACATTG AGAAAAGTGT GAATGAGATT
    CTAGGACTGG CAGAGTCTAG CCCAAACGAA CCCAAAGCAG CCACCCTGGC TGTTCCTCCA
    CCAGAAGATG TTCAACCTTC TGCACAGCAA CTGGAGCTGC TAGAACTTGA GATGAGGGCA
    AGAGCGATTA AAGCCCTAAT GAAAGCTGGT GATATAAAAA AGCCAGCCTA G

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_001161047.1
    CDS703..1353
    Translation

    Target ORF information:

    RefSeq Version NM_001167575.1
    Organism Homo sapiens(human)
    Definition Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 2, mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_001167575.1

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    ATGCTTCAGC AGTGCTTCTG TATTATAGGA GAGAAAAAGT TACAGAAGAT GCTTCCTGAT 
    GTGTTAAAGA ACTGTTCAAT AGAAGAAATT AAAAAACTAT GCCAGGAACA GTTAGAGCTC
    CTGTCTGAAA AAAAAATTTT GAAGATTCTT GAGGGTGACA ATGGAATGGA CTCTGATATG
    GAAGAGGAAG CAGATGATGG TTCTAAGATG GGATCTGATT TAGTCAGTCA GCAAGACATC
    TGTATAGATT CTGCTTCATC CGTGAGAGAG AATAAGCAAC CTGAAGGTTT GGAATTAAAA
    CAAGGAAAAG GGGAAGATAG TGATGTACTC AGTATAAATG CAGATGCTTA TGACAGCGAC
    ATAGAAGGCC CATGCAACGA AGAAGCAGCT GCTCCCGAGG CACCAGAAAA TACAGTCCAA
    AGTGAAGCTG GTCAGATAGA TGACCTGGAG AAAGACATTG AGAAAAGTGT GAATGAGATT
    CTAGGACTGG CAGAGTCTAG CCCAAACGAA CCCAAAGCAG CCACCCTGGC TGTTCCTCCA
    CCAGAAGATG TTCAACCTTC TGCACAGCAA CTGGAGCTGC TAGAACTTGA GATGAGGGCA
    AGAGCGATTA AAGCCCTAAT GAAAGCTGGT GATATAAAAA AGCCAGCCTA G

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    CloneID OHu13647
    Clone ID Related Accession (Same CDS sequence) NM_024828.3 , NM_024828.4
    Accession Version NM_024828.3 Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 1086bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2017-10-01
    Organism Homo sapiens(human)
    Product caspase activity and apoptosis inhibitor 1 isoform 1
    Comment Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from BP228742.1, BC071953.1 and AF131768.1. On Nov 6, 2009 this sequence version replaced NM_024828.2. Transcript Variant: This variant (1) encodes the longer isoform (1). ##Evidence-Data-START## Transcript exon combination :: BC071953.1, SRR1660809.10313.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2146236, SAMN01820693 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end.

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    661
    721
    781
    841
    901
    961
    1021
    1081
    ATGACGGGGA AAAAGTCCTC CCGGGAGAAA CGGCGCAAAC GTAGCAGTCA GGAGGCGGCC 
    GCAGCGCTCG CGGCCCCGGA CATCGTACCC GCGTTGGCCA GCGGCAGCAG TGGAAGCACT
    AGCGGCTGCG GGAGCGCCGG GGGCTGCGGG AGCGTCAGCT GCTGTGGGAA CGCCAATTTT
    AGTGGAAGTG TCACCGGCGG TGGGAGCGGC GGCAGCTGTT GGGGCGGGAG CAGCGTGGAG
    CGCAGCGAGC GCCGGAAGCG GAGGAGTACC GACTCTTCCA GCGTCTCGGG CTCCTTGCAG
    CAGGAAACTA AATATATTTT GCCAACTTTG GAAAAAGAAT TATTCTTGGC AGAGCACAGT
    GACCTTGAAG AAGGTGGACT GGACCTGACT GTGTCATTGA AACCAGTTAG TTTCTATATA
    TCAGACAAAA AAGAAATGCT TCAGCAGTGC TTCTGTATTA TAGGAGAGAA AAAGTTACAG
    AAGATGCTTC CTGATGTGTT AAAGAACTGT TCAATAGAAG AAATTAAAAA ACTATGCCAG
    GAACAGTTAG AGCTCCTGTC TGAAAAAAAA ATTTTGAAGA TTCTTGAGGG TGACAATGGA
    ATGGACTCTG ATATGGAAGA GGAAGCAGAT GATGGTTCTA AGATGGGATC TGATTTAGTC
    AGTCAGCAAG ACATCTGTAT AGATTCTGCT TCATCCGTGA GAGAGAATAA GCAACCTGAA
    GGTTTGGAAT TAAAACAAGG AAAAGGGGAA GATAGTGATG TACTCAGTAT AAATGCAGAT
    GCTTATGACA GCGACATAGA AGGCCCATGC AACGAAGAAG CAGCTGCTCC CGAGGCACCA
    GAAAATACAG TCCAAAGTGA AGCTGGTCAG ATAGATGACC TGGAGAAAGA CATTGAGAAA
    AGTGTGAATG AGATTCTAGG ACTGGCAGAG TCTAGCCCAA ACGAACCCAA AGCAGCCACC
    CTGGCTGTTC CTCCACCAGA AGATGTTCAA CCTTCTGCAC AGCAACTGGA GCTGCTAGAA
    CTTGAGATGA GGGCAAGAGC GATTAAAGCC CTAATGAAAG CTGGTGATAT AAAAAAGCCA
    GCCTAG

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_079104.3
    CDS114..1199
    Translation

    Target ORF information:

    RefSeq Version NM_024828.3
    Organism Homo sapiens(human)
    Definition Homo sapiens caspase activity and apoptosis inhibitor 1 (CAAP1), transcript variant 1, mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_024828.3

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    361
    421
    481
    541
    601
    661
    721
    781
    841
    901
    961
    1021
    1081
    ATGACGGGGA AAAAGTCCTC CCGGGAGAAA CGGCGCAAAC GTAGCAGTCA GGAGGCGGCC 
    GCAGCGCTCG CGGCCCCGGA CATCGTACCC GCGTTGGCCA GCGGCAGCAG TGGAAGCACT
    AGCGGCTGCG GGAGCGCCGG GGGCTGCGGG AGCGTCAGCT GCTGTGGGAA CGCCAATTTT
    AGTGGAAGTG TCACCGGCGG TGGGAGCGGC GGCAGCTGTT GGGGCGGGAG CAGCGTGGAG
    CGCAGCGAGC GCCGGAAGCG GAGGAGTACC GACTCTTCCA GCGTCTCGGG CTCCTTGCAG
    CAGGAAACTA AATATATTTT GCCAACTTTG GAAAAAGAAT TATTCTTGGC AGAGCACAGT
    GACCTTGAAG AAGGTGGACT GGACCTGACT GTGTCATTGA AACCAGTTAG TTTCTATATA
    TCAGACAAAA AAGAAATGCT TCAGCAGTGC TTCTGTATTA TAGGAGAGAA AAAGTTACAG
    AAGATGCTTC CTGATGTGTT AAAGAACTGT TCAATAGAAG AAATTAAAAA ACTATGCCAG
    GAACAGTTAG AGCTCCTGTC TGAAAAAAAA ATTTTGAAGA TTCTTGAGGG TGACAATGGA
    ATGGACTCTG ATATGGAAGA GGAAGCAGAT GATGGTTCTA AGATGGGATC TGATTTAGTC
    AGTCAGCAAG ACATCTGTAT AGATTCTGCT TCATCCGTGA GAGAGAATAA GCAACCTGAA
    GGTTTGGAAT TAAAACAAGG AAAAGGGGAA GATAGTGATG TACTCAGTAT AAATGCAGAT
    GCTTATGACA GCGACATAGA AGGCCCATGC AACGAAGAAG CAGCTGCTCC CGAGGCACCA
    GAAAATACAG TCCAAAGTGA AGCTGGTCAG ATAGATGACC TGGAGAAAGA CATTGAGAAA
    AGTGTGAATG AGATTCTAGG ACTGGCAGAG TCTAGCCCAA ACGAACCCAA AGCAGCCACC
    CTGGCTGTTC CTCCACCAGA AGATGTTCAA CCTTCTGCAC AGCAACTGGA GCTGCTAGAA
    CTTGAGATGA GGGCAAGAGC GATTAAAGCC CTAATGAAAG CTGGTGATAT AAAAAAGCCA
    GCCTAG

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

  • PubMed

    Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.
    PloS one6(9)e25284(2011)
    Zhang Y,Johansson E,Miller ML,J?nicke RU,Ferguson DJ,Plas D,Meller J,Anderson MW


    Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.
    Gut58(8)1078-83(2009 Aug)
    Trynka G,Zhernakova A,Romanos J,Franke L,Hunt KA,Turner G,Bruinenberg M,Heap GA,Platteel M,Ryan AW,de Kovel C,Holmes GK,Howdle PD,Walters JR,Sanders DS,Mulder CJ,Mearin ML,Verbeek WH,Trimble V,Stevens FM,Kelleher D,Barisani D,Bardella MT,McManus R,van Heel DA,Wijmenga C


    Large-scale characterization of HeLa cell nuclear phosphoproteins.
    Proceedings of the National Academy of Sciences of the United States of America101(33)12130-5(2004 Aug)
    Beausoleil SA,Jedrychowski M,Schwartz D,Elias JE,Vill?n J,Li J,Cohn MA,Cantley LC,Gygi SP


    DNA sequence and analysis of human chromosome 9.
    Nature429(6990)369-74(2004 May)
    Humphray SJ,Oliver K,Hunt AR,Plumb RW,Loveland JE,Howe KL,Andrews TD,Searle S,Hunt SE,Scott CE,Jones MC,Ainscough R,Almeida JP,Ambrose KD,Ashwell RI,Babbage AK,Babbage S,Bagguley CL,Bailey J,Banerjee R,Barker DJ,Barlow KF,Bates K,Beasley H,Beasley O,Bird CP,Bray-Allen S,Brown AJ,Brown JY,Burford D,Burrill W,Burton J,Carder C,Carter NP,Chapman JC,Chen Y,Clarke G,Clark SY,Clee CM,Clegg S,Collier RE,Corby N,Crosier M,Cummings AT,Davies J,Dhami P,Dunn M,Dutta I,Dyer LW,Earthrowl ME,Faulkner L,Fleming CJ,Frankish A,Frankland JA,French L,Fricker DG,Garner P,Garnett J,Ghori J,Gilbert JG,Glison C,Grafham DV,Gribble S,Griffiths C,Griffiths-Jones S,Grocock R,Guy J,Hall RE,Hammond S,Harley JL,Harrison ES,Hart EA,Heath PD,Henderson CD,Hopkins BL,Howard PJ,Howden PJ,Huckle E,Johnson C,Johnson D,Joy AA,Kay M,Keenan S,Kershaw JK,Kimberley AM,King A,Knights A,Laird GK,Langford C,Lawlor S,Leongamornlert DA,Leversha M,Lloyd C,Lloyd DM,Lovell J,Martin S,Mashreghi-Mohammadi M,Matthews L,McLaren S,McLay KE,McMurray A,Milne S,Nickerson T,Nisbett J,Nordsiek G,Pearce AV,Peck AI,Porter KM,Pandian R,Pelan S,Phillimore B,Povey S,Ramsey Y,Rand V,Scharfe M,Sehra HK,Shownkeen R,Sims SK,Skuce CD,Smith M,Steward CA,Swarbreck D,Sycamore N,Tester J,Thorpe A,Tracey A,Tromans A,Thomas DW,Wall M,Wallis JM,West AP,Whitehead SL,Willey DL,Williams SA,Wilming L,Wray PW,Young L,Ashurst JL,Coulson A,Bl?cker H,Durbin R,Sulston JE,Hubbard T,Jackson MJ,Bentley DR,Beck S,Rogers J,Dunham I